Sentinel-node biopsy for axillary staging in breast cancer: Results from a large prospective German multi-institutional trial

European Journal of Surgical Oncology

Volumn 30, Issue 3, 2004, Pages 252-259

  Kuehn, Thorsten ^a   Vogl, F D ^b   Helms, G ^c   Pueckler, S V ^c   Schirrmeister, H ^c   Strueber, R ^a   Koretz, K ^c   Kreienberg, R ^c  

^a Department of Gynaecology/Obstetrics   (Germany)

^b INSTITUTE FOR RENEWABLE ENERGY   (Italy)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Axilla; Breast cancer; False negative rate; Learning curve; Multicentre study; Sentinel node biopsy; Ultrasound

Indexed keywords

DISULFINE BLUE; NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EXPERIENCE; GERMANY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LEARNING; LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PALPATION; PATIENT SELECTION; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; REPRODUCIBILITY; SENTINEL LYMPH NODE BIOPSY; SURGEON; SURGICAL TRAINING;

EID: 1442319013     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.11.016     Document Type: Article

References (26)

1. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R. Long-term-morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncotogic and therapeutic factors. Breast Cancer Res Treat 2000;64:275-286.
2. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebo Breast Cancer Study Group. Eur J Cancer 1997;333:193-99.
3. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-1867.
4. Cody HS. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001;3:104-8.
5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-2350.
6. Roumen R, Kuijt GP, Liem IH, van Beek MWP. Treatment of 100 patients with senti net-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-1643.
7. Giuliano AE, Haigh PI, Brennan MB, Hansen NM et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel-node-negative breast cancer. J Clin Oncol 2000;18: 2553-2559.
8. Pizzocaro C, Rossini PL, Terzi A, Farfaglia R, Lazzari L, Simoncini E, Giubbini R. Sentinel node biopsy in breast cancer: The experience of Brescia Civic Hospital. Tumori 2000;86(4):309-311.
9. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Clin Oncol 2001;18: 3817-3827.
10. Stata Corporation, Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation, 1999.
11. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 1999;2(1):32-37.
12. McMasters KM, Tuttle TM, Carlson DJ, Brown CM et al. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional. practice when optimal technique is used. J Clin Oncol 2000; 18:2560-2566.
13. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Felman S. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339:941-946.
14. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233(1):51-59.
15. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thörn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 2001;88:1644-1648.
16. Heuser T, Rink T, Weller E, Fitz H, Zippel HH, Kreienberg R, Kuehn T. Impact of axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding. Breast Cancer Res Treat 2001;67:125-132.
17. Siegel BM, Mayzel KM, Love SM. Level I and II axillary dissection in the treatment of early stage breast cancer: An analysis of 259 consecutive patients. Arch Surg 1990;125: 114-117.
18. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232.
19. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher E, Jeong HJ, Wolmark N. Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241.
20. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HS III. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229(4):528-535.
21. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: Practical considerations. Arch Surg 1999;134(7):64-67.
22. Sanidas EE, Bree E, Tsiftis DD. How many cases are enough for accreditation in sentinel node biopsy in breast cancer? Am J Surg 2003;185:202-210.
23. De Freitas R, Costa MV, Schneider SV, Nicolau MA, Marussi E. The accuracy of uttrasond and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Oncol 1991;17:240-244.
24. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152: 765-772.
25. Tate JJT, Lewis V, Archer T, Guyer PG, Royte GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15;271-276.
26. Bonnema J, van Geel AN, van Ooijen B, Mali SPM, Tjiam SL, Henzen-Longmans SC, Schitz PIM, Wiggers T. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients. World J Surg 1997;21:270-274.